
The Biden administration failed to prioritize innovative solutions that could alleviate or prevent the worsening of this crisis. Instead, they relied on short-acting, marginally-effective COVID-19 vaccines while restricting the development and availability of new medicines that could dramatically change health outcomes for millions.
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance